Showing results (131-140 of 191) with videos related to

Sort By:
Pageof 20
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 27, 2026
Impact of weight loss on adverse events during chemoradiotherapy in patients with small cell lung cancer: a retrospective studyYoshimasa Saito, Mai Kawarade, Reiko Ando Makihara, et al.
Anticancer Research|November 4, 2021
Smoking History Predicts High Presence of TILs and Efficacy of PD-1 Blockade in PD-L1 Expression-negative Non-small Cell Lung Cancer PatientsYukiko Shimoda, Tatsuya Yoshida, Masayuki Shirasawa, et al.
Cancers|August 26, 2023
Whole Exome Sequencing of Thymoma Patients Exhibiting Exceptional Responses to Pemetrexed MonotherapyTomohiro Tanaka, Yasushi Goto, Masafumi Horie, et al.
JTO Clinical and Research Reports|April 3, 2023
Clinical Characteristics and Pharmacokinetics Change of Long-Term Responders to Antiprogrammed Cell Death Protein 1 Inhibitor Among Patients With Advanced NSCLCHitomi Jo, Tatsuya Yoshida, Shigehiro Yagishita, et al.
Scientific Reports|September 22, 2021
Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertionsChie Morita, Tatsuya Yoshida, Masayuki Shirasawa, et al.
Lung Cancer (Amsterdam, Netherlands)|April 9, 2022
Nivolumab versus pembrolizumab in previously-treated advanced non-small cell lung cancer patients: A propensity-matched real-world analysisMasahiro Torasawa, Tatsuya Yoshida, Shigehiro Yagishita, et al.
British Journal of Cancer|February 20, 2022
Comprehensive screening for drugs that modify radiation-induced immune responsesMasayuki Okumura, Junyan Du, Shun-Ichiro Kageyama, et al.
Cancer Medicine|April 16, 2023
Disease progression status during initial immune checkpoint inhibitor (ICI) affects the clinical outcome of ICI retreatment in advanced non-small cell lung cancer patientsMasahiro Torasawa, Tatsuya Yoshida, Yuki Takeyasu, et al.
Lung Cancer (Amsterdam, Netherlands)|April 21, 2026
Comparative analysis of therapeutic target protein expression in de novo and transformed small cell lung carcinomas using paired biopsy samplesSaori Murata, Jumpei Kashima, Hidehito Horinouchi, et al.
Clinical Lung Cancer|June 1, 2022
Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC PatientsYukiko Shimoda, Ryota Shibaki, Tatsuya Yoshida, et al.
Pageof 20